冷大气等离子体作为瘤治疗的现状和未来趋势
Xiaofeng Dai1,2, Jiale Wu1, Lianghui Lu1
1The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an 710061, China.
Biomolecules & therapeutics
|August 29, 2023
概括
冷大气等离子体 (CAP) 通过调节细胞氧化还原作用,显示出作为抗癌疗法的前景. 需要进一步的研究来确定敏感的瘤类型,并优化CAP在血瘤学中临床使用.
科学领域:
- 等离子体物理和化学
- 在瘤学瘤学.
- 生物医学工程 生物医学工程
背景情况:
- 冷大气等离子体 (CAP) 以其潜在的抗癌特性而闻名,作为氧化还原调节工具.
- 尽管有报道的成功,但由于细胞异质性和多样化的CAP器件设计,对CAP敏感的瘤类型存在缺乏共识.
- 这些因素阻碍了CAP作为可行的瘤治疗的临床转化.
研究的目的:
- 为了澄清响应CAP的瘤类型.
- 审查CAP调查的实验模型.
- 阐明CAP的管理策略和抗癌机制,以加速临床转化.
主要方法:
- 关于大气冷等离子体和癌症研究的文献综述.
- 用于等离子体瘤学研究的实验模型的分析.
- 检查CAP设备参数和管理策略.
- 研究CAP抗癌效应背后的分子机制.
主要成果:
- 特定癌症类型的鉴定,这些癌症类型对CAP有敏感性.
- 已建立和新兴的CAP研究实验模型的概述.
- 有效的CAP应用方法和参数设置的总结.
- 阐明关键信号通路和受CAP影响的细胞过程.
结论:
- 对CAP设备和实验协议的标准化对于可重现的结果至关重要.
- 对CAP的作用机制的进一步研究将完善其治疗应用.
- 针对CAP敏感瘤的有针对性的鉴定将加速其在血瘤学中的临床采用.
相关概念视频
Cancer Therapies
7.7K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.7K
Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
Tumor Immunotherapy
555
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
555
Inductively Coupled Plasma Atomic Emission Spectroscopy: Principle
695
Inductively coupled plasma (ICP) is the most widely used plasma source in atomic emission spectroscopy (AES), also known as Inductively Coupled Plasma Optical Emission Spectroscopy (ICP-OES). The ICP source, or torch, consists of three concentric quartz tubes with argon gas flowing through them. A spark from a Tesla coil initiates the ionization of argon, generating a high-temperature plasma.
The ions and electrons produced interact with the fluctuating magnetic field created by a water-cooled...
The ions and electrons produced interact with the fluctuating magnetic field created by a water-cooled...
695


